Norbert W. Bischofberger, EVP, R&D and CSO at GILEAD SCIENCES INC (GILD), sold 70,000 shares at $117.98 ($8.2M) on 2015-06-15, disclosed to the SEC on 2015-06-17.
Scheduled sale ($8.2M) by EVP, R&D and CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $116.98 | 21,837 | $2.6M | 31.0% |
| 2 | $117.98 | 48,163 | $5.7M | 69.0% |
| Total | $117.67 avg | 70,000 | $8.2M | 100% |
| Filing → |
| KRON | BUY | 2023-11-17 | $2.7M | — | Filing → |
| KRON | BUY | 2022-05-19 | $3.4M | — | Filing → |
| KRON | BUY | 2021-12-08 | $347K | — | Filing → |